Write your message
Volume 12, Issue 2 (Iranian Quarterly Journal of Breast Disease 2019)                   ijbd 2019, 12(2): 17-25 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Tahmasebi Fard Z. Relationships between Body Mass Index, Serum Leptin Levels, and 17β-Estradiol in Postmenopausal Women with Breast Cancer: A Case-Control Study. ijbd 2019; 12 (2) :17-25
URL: http://ijbd.ir/article-1-708-en.html
Biology group, Roudehen Branch, Islamic Azad of university, Roudehen, Iran , ztahmasebifard@yahoo.com
Abstract:   (4419 Views)
Introduction: There is a close relationship between the incidence of breast cancer and fat intake in different populations. Overweight and obesity during menopause can increase the risk of breast cancer in women. Hormones like estrogen and leptin are factors that affect the growth and proliferation of breast cells. The main purpose of this study was to evaluate the relationships between body mass index (BMI) and serum levels of leptin and 17β-estradiol in postmenopausal women with breast cancer.
Methods: Seventy-nine postmenopausal women with breast cancer and Seventy-nine healthy postmenopausal women, aged 50-75 years, were recruited for the study. After obtaining written informed consent and demographic data, blood samples were taken from all participants to assess the serum concentrations of hormones using ELISA.
Results: The mean BMI was 25.59 ± 0.34 kg/m2 for the cancer group, 23.21 ± 0.22 kg/m2 for the control group  (P = 0.001). The difference in serum concentration of 17beta-estradiol between the cancer group and the control group was significant (54.27 ± 1.91 and 46.44 ± 1.36 pg/ml, respectively, P = 0.001). The mean serum leptin level was significantly lower in the cancer group (41.05 ± 3.10 ng/ml) than in the control group (53.05 ± 4.83, 53 ng/ml) (P = 0.036).
Conclusion: Body mass index in both groups was significantly and positively correlated with serum levels of 17β-estradiol, but there was no significant correlation between BMI and serum leptin concentration. Postmenopausal women with BMI ˃ 25 and high serum concentrations of 17β-estradiol are probably susceptible to breast cancer.
Full-Text [PDF 670 kb]   (1556 Downloads)    
Conclusion: Body mass index in both groups was significantly and positively correlated with serum levels of 17β-estradiol, but there was no significant correlation between BMI and serum leptin concentration. Postmenopausal women with BMI ˃ 25 and high serum concentrations of 17β-estradiol are probably susceptible to breast cancer.

Type of Study: Research | Subject: Breast Diseases
Received: 2018/12/1 | Accepted: 2019/05/8 | Published: 2019/08/21

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Breast Diseases

Designed & Developed by: Yektaweb